Abavisani M[au] - Search Results

Year	Number of Results
2013	1
2019	2
2020	2
2021	2
2022	4
2023	9
2024	2

1

Effect of complementary and alternative medicine interventions on cancer related pain among breast cancer patients: A systematic review.

Behzadmehr R, Dastyar N, Moghadam MP, Abavisani M, Moradi M. Behzadmehr R, et al. Among authors: abavisani m. Complement Ther Med. 2020 Mar;49:102318. doi: 10.1016/j.ctim.2020.102318. Epub 2020 Jan 17. Complement Ther Med. 2020. PMID: 32147038

2

Bismuth nanoparticles against microbial infections.

Neamati F, Kodori M, Feizabadi MM, Abavisani M, Barani M, Khaledi M, Moghadaszadeh M, Azadbakht MK, Zeinali M, Fathizadeh H. Neamati F, et al. Among authors: abavisani m. Nanomedicine (Lond). 2022 Nov;17(27):2109-2122. doi: 10.2217/nnm-2022-0153. Epub 2023 Feb 14. Nanomedicine (Lond). 2022. PMID: 36786392 Review.

3

Common Clinical Features of Cases with Mpox Reinfection.

Keikha M, Abavisani M, Sahebkar A. Keikha M, et al. Among authors: abavisani m. Curr Drug Targets. 2023;24(15):1151-1154. doi: 10.2174/0113894501267823231103103344. Curr Drug Targets. 2023. PMID: 37946355 No abstract available.

4

Statins, allies against antibiotic resistance?

Abavisani M, Hoseinzadeh M, Khayami R, Kodori M, Soleimanpour S, Sahebkar A. Abavisani M, et al. Curr Med Chem. 2023 Aug 29. doi: 10.2174/0929867331666230829141301. Online ahead of print. Curr Med Chem. 2023. PMID: 37644745

5

Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli.

Abavisani M, Bostanghadiri N, Ghahramanpour H, Kodori M, Akrami F, Fathizadeh H, Hashemi A, Rastegari-Pouyani M. Abavisani M, et al. Lett Appl Microbiol. 2023 Feb 16;76(2):ovad023. doi: 10.1093/lambio/ovad023. Lett Appl Microbiol. 2023. PMID: 36754367 Review.

6

Relationships between Efflux Pumps and Emergence of Heteroresistance: A Comprehensive Study on the Current Findings.

Abavisani M, Kodori M, Akrami F, Radfar A, Hashemi A. Abavisani M, et al. Can J Infect Dis Med Microbiol. 2022 Sep 19;2022:3916980. doi: 10.1155/2022/3916980. eCollection 2022. Can J Infect Dis Med Microbiol. 2022. PMID: 36249589 Free PMC article. Review.

7

CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance.

Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A. Abavisani M, et al. Drug Resist Updat. 2023 May;68:100948. doi: 10.1016/j.drup.2023.100948. Epub 2023 Feb 10. Drug Resist Updat. 2023. PMID: 36780840 Review.

8

Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosis.

Abavisani M, Khoshrou A, Sahebkar A. Abavisani M, et al. Drug Discov Today. 2024 Mar;29(3):103909. doi: 10.1016/j.drudis.2024.103909. Epub 2024 Feb 1. Drug Discov Today. 2024. PMID: 38307380 No abstract available.

9

Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis.

Abavisani M, Keikha M. Abavisani M, et al. Ann Clin Microbiol Antimicrob. 2023 Aug 10;22(1):70. doi: 10.1186/s12941-023-00627-6. Ann Clin Microbiol Antimicrob. 2023. PMID: 37563660 Free PMC article.

10

Mutations in SARS-CoV-2 structural proteins: a global analysis.

Abavisani M, Rahimian K, Mahdavi B, Tokhanbigli S, Mollapour Siasakht M, Farhadi A, Kodori M, Mahmanzar M, Meshkat Z. Abavisani M, et al. Virol J. 2022 Dec 18;19(1):220. doi: 10.1186/s12985-022-01951-7. Virol J. 2022. PMID: 36528612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year